To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars.

Adv Ther · 2018 · PMC6096951 · PMID 29873005

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Additional evidence taken from registry studies, as well as single-center experiences, has shown a possible trend for patients to discontinue biosimilar treatment, mainly due to reported lack of effectiveness or AEs [ 18 – 24 ].

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.